News Search
|
All News Topics
>
Mesothelioma
;
Press Releases by Industry Channel
>
All Mesothelioma Press Releases
EMEA-001666-PIP01-14-M01
P/0171/2016: EMA decision of 17 June 2016 on the acceptance of a modification of an agreed paediatric investigation plan for atrasentan (hydrochloride) (EMEA-001666-PIP01-14-M01)
AdoptedReference Number: EMA/385694/2016
Powered by
Distribution channels:
Healthcare & Pharmaceuticals Industry
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
